PUBLISHER: The Business Research Company | PRODUCT CODE: 1948610
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948610
Vascular grafts are used to repair damaged or blocked blood vessels during surgical procedures such as vascular grafting or bypass surgery. The graft redirects blood flow around partially or fully blocked arteries, improving circulation by rerouting blood to healthy vessels.
The main products in the vascular grafts market include hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery bypass grafts. Endovascular stent grafts are minimally invasive solutions used to treat aortic aneurysms and are employed to assess abdominal pain, disease-related symptoms, and aneurysm size. The raw materials used include polyester grafts, expanded polytetrafluoroethylene (ePTFE), polyurethane grafts, and biosynthetic grafts. The applications include coronary artery disease, aneurysms, vascular occlusions, and renal failure, and these grafts are used by end users such as hospitals and ambulatory surgical centers.
Tariffs on imported synthetic graft materials, biological scaffolds, and delivery systems have increased device costs. Regions heavily reliant on imports, such as Europe and North America, have encouraged domestic manufacturing of vascular grafts, accelerating innovation in bioengineered grafts.
The vascular grafts market research report is one of a series of new reports from The Business Research Company that provides vascular grafts market statistics, including vascular grafts industry global market size, regional shares, competitors with a vascular grafts market share, detailed vascular grafts market segments, market trends and opportunities, and any further data you may need to thrive in the vascular grafts industry. This vascular grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vascular grafts market size has grown strongly in recent years. It will grow from $3.86 billion in 2025 to $4.1 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rise in bypass surgeries, advancements in synthetic and biological graft materials, expanding hospital and cardiac surgery infrastructure, growing awareness of vascular disorders.
The vascular grafts market size is expected to see strong growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of tissue-engineered grafts, AI-driven patient-specific graft design, growth in minimally invasive surgery, integration with intraoperative imaging, increasing geriatric population requiring vascular interventions. Major trends in the forecast period include bioengineered and tissue-engineered grafts, ai-assisted graft design, minimally invasive implant techniques, integration with imaging and monitoring systems, customized patient-specific grafts.
The rising incidence of cardiovascular diseases is increasingly supporting the expansion of the vascular grafts market going forward. Cardiovascular diseases include a group of disorders affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The increase in cardiovascular diseases is largely associated with unhealthy dietary habits, including excessive consumption of processed foods and fats that elevate cholesterol levels and cardiovascular risk. Vascular grafts play a critical role in cardiovascular treatment by bypassing or replacing damaged blood vessels, improving blood circulation, and reducing complication risks. These grafts enhance patient outcomes by enabling effective surgical interventions and supporting long-term cardiovascular health. For example, in October 2024, according to the Centers for Disease Control, a US-based government agency, approximately 919,032 deaths in 2023 were attributed to cardiovascular disease, accounting for one in every three deaths. As a result, the rising incidence of cardiovascular diseases is strengthening demand for vascular grafts.
Leading companies operating in the vascular grafts market are focused on introducing innovative products to strengthen their competitive position. Innovative products in this market involve advanced technologies designed to improve treatment of vascular disorders and overcome limitations of traditional grafts. For example, in January 2023, Viz.ai, a US-based medical technology company, launched the AI-powered Viz Vascular Suite. The platform uses artificial intelligence to analyze imaging data such as CT and ECG scans for suspected vascular disease and automatically alerts care teams, enabling rapid, coordinated, and HIPAA-compliant communication among specialists.
In April 2025, Healthcare Holding Switzerland AG, a Switzerland-based medical technology services provider, acquired Schaublin Medica SA for an undisclosed amount. With this acquisition, Healthcare Holding aims to reinforce its cardiovascular and vascular surgery portfolio by integrating Schaublin Medica's expertise in vascular grafts, endoprostheses, stents, and drug-coated balloon catheter technologies. Schaublin Medica SA is a Switzerland-based cardiovascular medical device company specializing in vascular graft solutions.
Major companies operating in the vascular grafts market are B. Braun Melsungen AG, Abbott Laboratories, W. L. Gore & Associates Inc., Terumo Medical Corporation, Medtronic Plc, Endologix, Cook Medical, MicroPort, CR Bard, Biovic, Novomed Incorporation Private Limited, Gore Medical, LeMaitre Vascular, JOTEC, Vascutek, RUA Life Sciences, Vascular Flow Technologies, Bolton Medical, Cryolife, Vascular Graft Solutions Ltd.
North America was the largest region in the vascular grafts market in 2025. Western Europe was the second largest region in the vascular grafts market report. The regions covered in the vascular grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vascular grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vascular grafts market consists of sales of polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vascular Grafts Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vascular grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vascular grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular grafts market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.